ClinicalTrials.Veeva

Menu

The Neuromarker S-100B in Patients With Different Types of Intracranial Injury

Medical University of Vienna logo

Medical University of Vienna

Status

Completed

Conditions

Traumatic Brain Injury
Trauma

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Abstract:

The most widely studied neuro-markers in traumatic brain injury (TBI) are S100B and neurone specific enolase (NSE). S-100B is localized in astroglia. This marker is used to predict neuronal damage caused by traumatic brain injury. The investigators conduct a study to derive and validate the measurement of S-100B in serum of patients with different types traumatic brain injuries.

Full description

The neuromarker S-100B is a well established tool for decision making in patients traumatic brain injury (TBI)in Europe. In many hospitals S-100B is used routinely as a part of a set of high- and medium risk factors aiding the decision to perform a cranial computed tomography (CCT) in patients with minor head injury (MHI). In patients with severe head injury Raabe et al. found a significant correlation between the S-100B levels and unfavourable outcome in patients with severe brain injury with serum levels higher than 0.50 μg/l measured 24h after injury. The average level of the neuromarker, compared with other studies. The study of Biberthaler et al. showed highest levels in patients with epidural hematomas, followed by subdural, subarachnoidal and intracerebral hematomas. On the contrary the average S-100B levels of patients with epidural hematomas featured in a study by Unden et al. published in 2005 displayed normal levels (<0.2 μg/L). They concluded that S-100B was unreliable as a marker for epidural hematomas.

Aim of the study Validation of S-100B in patients with intracerebral, epidural, subdural, and subarachnoidal hematoma, brain edema and concussion (Group 1-6), to find evidence which kind of injury leads to which level of elevation of the neuromarker measured in peripheral blood.

Enrollment

1,800 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • all patients with traumatic brain injury

Exclusion criteria

  • patients without traumatic brain injury

Trial design

1,800 participants in 6 patient groups

Epidural H.
Description:
patients with hematoma epidurale
Subdural H.
Description:
patients with hematoma subdurale
Subarachnoidal H.
Description:
patients with hematoma subarachnoidale
Intracerebral H.
Description:
patients with hematoma intracerebrale
E. cerebri
Description:
patients with edema cerebri
Concussion
Description:
patients with concussion

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems